Gelesis Holdings Inc Asset Turnover Ratio (GLS), as of second quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Gelesis Holdings Inc   (GLS)
 

Gelesis Holdings Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Gelesis Holdings Inc 's asset turnover ratio, the ratio that measures the ability of Gelesis Holdings Inc 's assets to generate revenue, sequentially decreased to 0.11 in the second quarter (Jun 30 2023), which does not come as a surprise, as the Gelesis Holdings Inc continue to experience difficult business climate.

Within sector 184 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2023 compared to the preceding quarter from 3364 to 3418.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GLS Asset Turnover Ratio (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Asset Change -30.78 % -34.9 % -62.62 % -52.77 % -49.97 %
Y / Y Revenue Change -87.66 % -76.67 % -9.13 % 120.7 % 311.98 %
Asset Turnover Ratio (TTM) 0.11 0.17 0.2 0.15 0.11
GLS's Total Ranking # 3418 # 3364 # 3602 # 0 # 0
Seq. Asset Change -2.79 % -4.47 % -20.9 % -5.77 % -8.58 %
Seq. Revenue Change -36.85 % -33.3 % -60.49 % -25.87 % 19.42 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 185
Healthcare Sector # 515
Overall Market # 3418

Asset Turnover Ratio Statistics
High Average Low
0.2 0.16 0.11
(Dec 31 2022)   (Jun 30 2023)




GLS Company Profile • Back to GLS Efficiency Comparisons • Compare GLS Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2023 Assets at quarter ending Jun 30 2023
Becton Dickinson And Company  0.35 $ 18,508.000  Millions$ 53,319.750  Millions
Jazz Pharmaceuticals Plc  0.35 $ 3,762.904  Millions$ 10,881.897  Millions
Amgen Inc   0.35 $ 26,582.000  Millions$ 76,952.500  Millions
Medtronic Plc  0.34 $ 31,558.000  Millions$ 91,486.500  Millions
Lite Strategy Inc   0.34 $ 48.816  Millions$ 141.545  Millions
Orgenesis Inc   0.34 $ 21.867  Millions$ 63.460  Millions
Teva Pharmaceutical Industries Limited  0.34 $ 15,017.000  Millions$ 43,706.000  Millions
Procept Biorobotics Corporation  0.34 $ 101.634  Millions$ 297.568  Millions
Assure Holdings Corp   0.34 $ 9.323  Millions$ 27.325  Millions
Immucell Corporation  0.34 $ 15.197  Millions$ 44.598  Millions
United Therapeutics Corporation  0.34 $ 2,110.900  Millions$ 6,213.350  Millions
Zimmer Biomet Holdings Inc   0.34 $ 7,195.500  Millions$ 21,234.275  Millions
Cytek Biosciences Inc   0.34 $ 175.063  Millions$ 517.100  Millions
Sonendo Inc   0.34 $ 42.898  Millions$ 127.069  Millions
Esperion Therapeutics Inc   0.34 $ 87.913  Millions$ 261.803  Millions
Arrowhead Pharmaceuticals Inc   0.33 $ 256.213  Millions$ 767.761  Millions
Avid Bioservices Inc   0.33 $ 148.888  Millions$ 446.713  Millions
Durect Corp  0.33 $ 19.427  Millions$ 58.894  Millions
Aurinia Pharmaceuticals Inc   0.33 $ 160.117  Millions$ 489.954  Millions
Bausch Health Companies Inc   0.32 $ 8,350.000  Millions$ 25,733.000  Millions
Evoke Pharma Inc   0.32 $ 3.570  Millions$ 11.070  Millions
Sarepta Therapeutics Inc   0.32 $ 1,003.434  Millions$ 3,117.548  Millions
Prestige Consumer Healthcare Inc   0.32 $ 1,129.339  Millions$ 3,512.125  Millions
Telesis Bio Inc   0.32 $ 95.322  Millions$ 297.480  Millions
Amarin Corp Plcuk  0.32 $ 281.198  Millions$ 878.672  Millions
Orthopediatrics Corp  0.32 $ 137.091  Millions$ 429.735  Millions
Viatris Inc   0.32 $ 15,601.900  Millions$ 49,167.550  Millions
Sotera Health Company  0.31 $ 975.472  Millions$ 3,104.345  Millions
Comera Life Sciences Holdings Inc   0.31 $ 1.099  Millions$ 3.501  Millions
Biocorrx Inc   0.31 $ 0.237  Millions$ 0.763  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.